Abstract
Shank3 is an autism spectrum disorder-associated postsynaptic scaffold protein that links glutamate receptors to trafficking and signaling networks within the postsynaptic density. Shank3 is required for synaptic scaling, a form of homeostatic plasticity that bidirectionally modulates postsynaptic strength to stabilize neuronal activity. Shank3 undergoes activity-dependent phosphorylation/dephosphorylation at S1586/S1615, and dephosphorylation at these sites is critical for enabling synaptic upscaling. Here, we probe the molecular machinery downstream of Shank3 dephosphorylation that allows for synaptic upscaling in cultured rat neurons of either sex. We first show that a phosphomimetic mutant of Shank3 has reduced binding ability and interaction with long-form Homer1, a postsynaptic protein also crucial for scaling and a known binding partner of Shank3. Since metabotropic glutamate receptor 5 (mGluR5) has been shown to associate with Shank3 through long-form Homer1, we manipulated mGluR1 and mGluR5 signaling with either noncompetitive or competitive inhibitors and found that only competitive inhibition (which targets agonist-dependent signaling) impairs synaptic upscaling. Furthermore, we found that mGluR5 activation rescues synaptic upscaling in the presence of phosphomimetic Shank3 and thus is downstream of Shank3 phosphorylation. Finally, we identify signaling pathways downstream of Group I mGluRs that are necessary for upscaling. Altogether, these data show that activity-dependent dephosphorylation of Shank3 remodels the Shank3/Homer1/mGluR signaling pathway to favor agonist-dependent mGluR signaling, which is necessary to enable synaptic upscaling. More broadly, because downscaling is thought to require agonist-independent mGluR5 signaling, these findings demonstrate that synaptic up- and downscaling rely on distinct functional configurations of the same signaling elements.